What is Ironwood Pharmaceuticals's price / earnings?

Ironwood Pharmaceuticals (IRWD) reported price / earnings of 5.6× in Q1 2026.

What is the long-term trend for Ironwood Pharmaceuticals's price / earnings?

Over 4 years (2020 to 2025), Ironwood Pharmaceuticals's price / earnings has grown at a 7.2% compound annual growth rate (CAGR), from 17.3× to 22.8×.

What does price / earnings mean?

Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.

Ironwood Pharmaceuticals IRWD Price / earnings

Price / earnings at other companies

Eton Pharmaceuticals, Inc.ETON

105.5×—

Rigel PharmaceuticalsRIGL

1.4×-7.3×

ANI PharmaceuticalsANIP

18.7×—

Catalyst PharmaceuticalCPRX

13.7×-1.3×

Neurocrine BiosciencesNBIX

19.8×-16.3×

Kiniksa Pharmaceuticals International, plcKNSA

50.4×—

Other financials

Income statement

See full

Revenue$106.5M+159%

Operating income$72.6M+349%

Net income$40.8M+209%

EPS (diluted)$0.24+204%

Balance sheet

See full

Cash & equivalents$220.5M+103%

Total debt$212.4M+1,323%

Total equity-$217.1M+35.0%

Total assets$434.6M+32.8%

Cash flow

See full

Operating cash flow$5.1M-74.3%

CapEx-—

Free cash flow$74.6M+390%

Valuation

See full

Market cap$632.12M+457%

Enterprise value$624M+3,024%

P/S1.8×+1.4×

Profitability

See full

Gross margin99.2%—

Operating margin55.4%+38.7pp

Net margin28.3%+22.3pp

FCF margin24.7%-11.1pp

Returns & leverage

See full

Return on equity29.7%-138pp

Debt / equity0×-0.5×

Current ratio1.4×-1.9×

Where this comes from

Calculated from Ironwood Pharmaceuticals’s reported figures.

market cap/net income=5.6×

Based on the most recent quarter.

The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ironwood Pharmaceuticals's price / earnings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ironwood Pharmaceuticals's price / earnings?: Ironwood Pharmaceuticals (IRWD) reported price / earnings of 5.6× in Q1 2026.
What is the long-term trend for Ironwood Pharmaceuticals's price / earnings?: Over 4 years (2020 to 2025), Ironwood Pharmaceuticals's price / earnings has grown at a 7.2% compound annual growth rate (CAGR), from 17.3× to 22.8×.
What does price / earnings mean?: Market capitalization at the quarter end divided by trailing-twelve-month net income. The price the market pays for each dollar of trailing earnings.